| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6828858 | Schizophrenia Research | 2008 | 6 Pages |
Abstract
This analysis provides further evidence for differential antipsychotic metabolic liabilities, and confirms signals for the effects of olanzapine and quetiapine on serum TG seen in earlier CATIE analyses. Future consensus recommendations will clarify the role of nonfasting TG monitoring in routine clinical practice.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jonathan M. Meyer, Vicki G. Davis, Joseph P. McEvoy, Donald C. Goff, Henry A. Nasrallah, Sonia M. Davis, Gail L. Daumit, John Hsiao, Marvin S. Swartz, T. Scott Stroup, Jeffrey A. Lieberman,